Author Question: A patient who is a missionary has returned from Africa to the United States and has completed ... (Read 67 times)

jerry coleman · **on:** Jul 23, 2018

A patient who is a missionary has returned from Africa to the United States and has completed treatment for an acute attack of P. vivax malaria. The provider has determined that clinical cure has been achieved.

The nurse will expect to teach this patient about:
a. beginning medications for a radical cure.
b. beginning suppressive therapy.
c. reporting visual disturbances and headaches.
d. using insect repellents and mosquito netting.

Question 2

The nurse is caring for a newly admitted African American patient who has just returned from a mission trip to Africa. The patient contracted malaria and is being treated with primaquine. What will the nurse monitor?

a. The patient's blood for evidence of hyperlipidemia
b. The patient's eyes for evidence of icterus
c. The patient's skin for photosensitivity
d. The patient's urinary output for evidence of darkening urine

mjbamaung · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Once a clinical cure has been achieved with treatment of an acute attack, radical cure is begun if the patient is out of a malaria-endemic region and not likely to become reinfected. Because this patient has returned to the United States, radical cure therapy may begin. Suppressive therapy is used to prevent infection in individuals traveling to areas where malaria is endemic. Insect repellants and mosquito netting are nondrug measures to prevent infection and are not necessary for this patient.

Answer to Question 2

ANS: D
The nurse should frequently monitor the patient's urine for evidence of hemoglobin, indicating hemolysis, which is marked by darkening urine. The patient need not be monitored for photosensitivity, because primaquine does not cause that condition. The patient need not be monitored for icterus, because primaquine does not cause icterus. The patient's blood need not be monitored for evidence of hyperlipidemia.